Details for New Drug Application (NDA): 201831
✉ Email this page to a colleague
The generic ingredient in DESMOPRESSIN ACETATE is desmopressin acetate. There are twenty drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the desmopressin acetate profile page.
Summary for 201831
Tradename: | DESMOPRESSIN ACETATE |
Applicant: | Glenmark Pharms Ltd |
Ingredient: | desmopressin acetate |
Patents: | 0 |
Suppliers and Packaging for NDA: 201831
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
DESMOPRESSIN ACETATE | desmopressin acetate | TABLET;ORAL | 201831 | ANDA | Glenmark Pharmaceuticals Inc.,USA | 68462-275 | 68462-275-01 | 100 TABLET in 1 BOTTLE (68462-275-01) |
DESMOPRESSIN ACETATE | desmopressin acetate | TABLET;ORAL | 201831 | ANDA | Glenmark Pharmaceuticals Inc.,USA | 68462-275 | 68462-275-10 | 1000 TABLET in 1 BOTTLE (68462-275-10) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 0.1MG | ||||
Approval Date: | May 28, 2015 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 0.2MG | ||||
Approval Date: | May 28, 2015 | TE: | AB | RLD: | No |
Complete Access Available with Subscription